This message was sent to ##Email##
Jeff House, DO, FACP
Carmen Isache, MD
Carlos Palacio, MD
Pramod Reddy, MD
Elisa Sottile, MD
“University of FL College of Medicine - Jacksonville has been sending Residents to the Southern Regional Meeting for over 10 years. We are very thankful for the opportunity for our residents to present their work and learn from the meeting. Another reason why we love the AFMR is that abstracts are published in their Journal of Investigative Medicine which is PubMed indexed, thereby counting toward the scholarly requirement with the ACGME.”
- Lorna Matos, C-TAGME, Division Administrator, Graduate Medical Education
AFMR Departmental/Group Membership:
In addition to the individual member benefits, the institution is entitled to the following:
- Complimentary job listings in AFMR's online Job Postings
- Link to your institution from this page
- Tier 1 only
The American Physiological Society (APS) will host the “Physiological Bioenergetics: Mitochondria from Bench to Bedside” conference August 27–30 in San Diego. The meeting will bring together cross-disciplinary experts who study the mitochondria, which provide the energy to individual cells.
Check out these featured articles in the September issue of The Journal of Pharmacology and Experimental Therapeutics available now:
“The Office of Public Affairs created a new factsheet, “The National Science Foundation: Fundamental Research Leads to Discovery,” which highlights the importance of NSF funding to basic science and includes graphics on NSF funding trends and overall funding sources for basic science research.
Given the proposed cut for the agency in the President’s FY 2018 budget and the funding recommendations for FY 2018 approved recently by the Senate Appropriations Committee – decreasing support for NSF by $161 million from FY 2017 – this new factsheet can be a helpful advocacy tool.” Todd Bentsen, Director of Communications, Office of Public Affairs
October 16, 2017 • 10 a.m.-1:30 p.m.
Robert C. Byrd Center for Congressional History and Education
Senator Joe Manchin (D-W.Va.) and
Senator Shelley Moore Capito (R-W.Va.)
Research!America’s president and CEO Mary Woolley will release results of a new survey of West Virginians on medical and health research.
The event, which will be live-streamed, will explore the current and future roles of innovation and research as catalysts to economic growth in West Virginia and as solutions to major health threats including the opioid epidemic.
Research!America’s National Health Research Forum sparks candid conversations among top leaders in government, industry, patient advocacy and academia about “in the moment” issues that could impact the trajectory of medical and health research and innovation. With such uncertainty regarding the future of our nation’s scientific enterprise, thought-leaders will come together to discuss potential solutions to challenges that could slow the pace of scientific progress. READ MORE
PAI-1 levels are related to insulin resistance and carotid atherosclerosis in subjects with familial combined hyperlipidemia
Arturo Carratala, Sergio Martinez-Hervas, Enrique Rodriguez-Borja, Esther Benito, José T Real, Guillermo T Saez, RafaelCarmena, Juan F Ascaso
DOI: 10.1136/jim-2017-000468 Published 19 August 2017
Physician scientists should learn how to program
Ben S Gerber, Thomas Kannampallil, Spyros Kitsiou, Paul S Heckerling
DOI: 10.1136/jim-2017-000573 Published 19 August 2017
The impact of statin therapy on survival for inhospital cardiac arrest
Rami Khoury Abdulla, Ed Kheder, Raymond Yeow, Shaiva Ginoya Meka, Omar Yaldo, Amr E Abbas
DOI: 10.1136/jim-2017-000475 Published 20 August 2017
Stay informed about JIM-HICR and register for e-alerts.
Michael McPhaul, MD
Ketoacidosis With Canagliflozin Prescribed for Phosphoinositide 3-Kinase Inhibitor–Induced Hyperglycemia: A Case Report
Many phosphoinositide-3-kinase (PI3K) inhibitors are under trial for cancer treatment. We present a patient taking taselisib who developed ketoacidosis within 1 week of starting canagliflozin. Case Description. A 69-year-old female patient with no previous history of diabetes mellitus was enrolled in a clinical trial for taselisib therapy in stage IV breast cancer. Hyperglycemia treatment with metformin was insufficient and not tolerated. The addition of canagliflozin daily resulted in ketoacidosis and hospitalization within 1 week. Conclusions. This case report brings together 2 poorly understood and relatively understudied disorders of glucose homeostasis: hyperglycemia due to PI3K inhibition and euglycemic ketoacidosis due to dehydration/SGLT2 inhibition. It demonstrates the complexities of glucose management in the setting of PI3K inhibition. PI3K stimulation (via insulin) in this setting is counterintuitive; therefore, non–insulin-mediated therapies (eg, metformin, thiazolidinediones) might be favored over insulin-mediated therapies. READ MORE
Stay informed about JIM-HICR and register for e-alerts.
American College of Clinical Pharmacy
To date, the relationship between antimuscarinics for overactive bladder (OAB) syndrome and depressive disorder still remains unclear. Therefore, this retrospective cohort study examined the association between antimuscarinic use and the subsequent risk of depressive disorder using a population-based data set. This study used data from the Taiwan Longitudinal Health Insurance Database 2005. We selected 1952 OAB women who received antimuscarinics as the study cohort and 9760 OAB women who did not receive antimuscarinics as the comparison cohort. Each subject was tracked for 3 years from her index date to determine all those who were subsequently diagnosed with depressive disorder.
Fibrosis after lung injury is related to poor outcome, and idiopathic pulmonary fibrosis (IPF) can be regarded as an exemplar. Vascular endothelial growth factor (VEGF)-A has been implicated in this context, but there are conflicting reports as to whether it is a contributory or protective factor. Differential splicing of the VEGF-A gene produces multiple functional isoforms including VEGF-A165a and VEGF-A165b, a member of the inhibitory family. To date there is no clear information on the role of VEGF-A in IPF.
The objectives of this report are to review the mechanisms of biotin interference with streptavidin/biotin-based immunoassays, identify automated immunoassay systems vulnerable to biotin interference, describe how to estimate and minimize the risk of biotin interference in vulnerable assays, and review the literature pertaining to biotin interference in endocrine function tests.
|January 25-27, 2018
||Western Medical Research Conference
|February 22-24, 2018
||Southern Regional Meeting
||New Orleans, LA
||Eastern Regional Meeting
|April 19-21, 2018
||Translational Science 2018
|April 21-25, 2018
|| Experimental Biology 2018
||San Diego, CA
|April 26-27, 2018
||2018 Combined Annual Meeting of CSCTR & MWAFMR
| || |
Connect with AFMR
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Natalie Thomas, Assistant Executive Editor, 469-420-2635 | Contribute news
MingMing Ning, AFMR Chair, Publishing Committee, 978-927-8330 | www.afmr.org
Elissa Klein, AFMR Executive Director, 978-927-8330 | www.afmr.org
American Federation for Medical Research
500 Cummings Center, Suite 4400 | Beverly, MA 01915 | 978-927-8330 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox.
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063